BioRem Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
For the six months, sales was CAD 7.45 million compared to CAD 10.64 million a year ago. Net loss was CAD 0.650218 million compared to net income of CAD 0.06402 million a year ago. Basic loss per share from continuing operations was CAD 0.042 compared to basic earnings per share from continuing operations of CAD 0.004 a year ago. Diluted loss per share from continuing operations was CAD 0.042 compared to diluted earnings per share from continuing operations of CAD 0.004 a year ago.